A cheaper, safer CBD alternative? Scientists discover new synthetic CBD analogue alleviates seizures in rats
Findings of the study are the basis of a new start-up, Syncanica, which is developing commercial applications of the new H2CBD compound
Findings of the study are the basis of a new start-up, Syncanica, which is developing commercial applications of the new H2CBD compound